-->
About
Who We Are
Management Team
Board of Directors
Scientific Advisors
Research
Pipeline Overview
Plinabulin
Other Pipeline
Protein Degradation
Posters & Publications
Collaboration
Expanded Access Policy
News & Media
Press Releases
Media Coverage
Investors
Stock Information
Events & Presentations
Financials & Filings
Corporate Governance
Contact Us
Press Releases
Press Releases
Media Coverage
Press Releases
March 30, 2020
BeyondSpring Initiates New Drug Application Rolling Submission for Plinabulin in China for Chemotherapy-Induced Neutropenia
March 23, 2020
BeyondSpring's Plinabulin May Prevent Tissue Iron Overload in Anemic Cancer Patients Receiving Chronic Blood Transfusions During Chemotherapy
March 11, 2020
BeyondSpring Files for Patent Protection on BPI-002 for the Treatment of Viral Infections Including COVID-19
February 10, 2020
BeyondSpring's Plinabulin Stimulates Both the Adaptive and Innate Immune System in Cancer Patients
January 23, 2020
BeyondSpring Appoints Pharma Veterans Drs. Daniel Zabrowski and Ramon Mohanlal to Company's Board of Directors
January 6, 2020
BeyondSpring Strengthens Executive Rank for Pipeline Expansion and Commercialization Readiness in China
December 19, 2019
BeyondSpring Publishes Report on Benefits and Mechanism of Plinabulin in Reducing Neutropenia with Multiple Chemotherapies
December 18, 2019
BeyondSpring Provides Third-Quarter 2019 Operational and Financial Results Update
December 11, 2019
BeyondSpring to Host Third-Quarter 2019 Financial Results and Operational Update Conference Call on December 18, 2019
目前在第
5
页,
共有
7
页,
共有
57
条记录
第一页
上一页
3
4
5
6
7
下一页
最后一页
跳转到
页
Terms of Use
© 2020 BeyondSpring Inc. All rights reserved.